Digital Diabetes Management Market by type (Handheld Devices and Wearable Devices), Product (Continuous blood glucose monitoring systems, Smart Glucose Meter, Smart Insulin Pumps, Smart Insulin Pens and Apps): Global Opportunity Analysis and Industry Forecast, 2019-2026
The global digital diabetes management market was valued at $3,375.8 million in 2018 and is projected to reach $17,118.7 million by 2026, registering a CAGR of 22.5% from 2019 to 2026. Diabetes is one of the most prevalent chronic disease that occurs due to malfunctioning of pancreas. The condition arises when pancreas do not produce enough insulin, or the body is unable to effectively utilize the insulin that has been produced. As per the data published by WHO, in 2018, the number of people suffering with diabetes has significantly risen from 108 million in 1980 to approximately 422 million in 2014. The prevalence of diabetes across the glove has increased from 4.7% to 8.5%. In 2016, around 1.6 million deaths occurred due to diabetes. Thus, it is essential to manage diabetes in order to maintain blood sugar levels in the human body.
Diabetes management includes measuring & recording blood sugar levels, measuring carbohydrate intake, along with tracking exercises and day-to-day activities. Thus, tracking these activities digitally offers continuous patient monitoring allowing the patients as well as physicians to better diagnose the current condition and suggest medications accordingly.
Prominent players in the market have adopted various strategies such as partnerships, product approvals and product launching for maintaining their share in the global digital diabetes management thereby addressing the evolving healthcare needs amongst the patients and healthcare providers.
The major factors driving the growth of the market are increase in adoption of smartphones & tablets coupled with healthcare apps and surge in the diabetic population globally. In contrast to these, the market growth is hampered by lack of awareness regarding digital diabetes management in developing countries and patient data privacy concerns. On the contrary, emerging markets offer significant opportunities for the growth of global digital diabetes management market.
The global digital diabetes management market is segmented based on type, product and region. Based on type, the market is categorized into Handheld Devices and Wearable Devices. Based on product, the digital diabetes management market divided into Continuous blood glucose monitoring systems, Smart Glucose Meter, Smart Insulin Pumps, Smart Insulin Pens and Apps. Based on region, the market is analyzed across North America, Europe, Asia-Pacific and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
ByType
Diabetes management includes measuring & recording blood sugar levels, measuring carbohydrate intake, along with tracking exercises and day-to-day activities. Thus, tracking these activities digitally offers continuous patient monitoring allowing the patients as well as physicians to better diagnose the current condition and suggest medications accordingly.
Prominent players in the market have adopted various strategies such as partnerships, product approvals and product launching for maintaining their share in the global digital diabetes management thereby addressing the evolving healthcare needs amongst the patients and healthcare providers.
The major factors driving the growth of the market are increase in adoption of smartphones & tablets coupled with healthcare apps and surge in the diabetic population globally. In contrast to these, the market growth is hampered by lack of awareness regarding digital diabetes management in developing countries and patient data privacy concerns. On the contrary, emerging markets offer significant opportunities for the growth of global digital diabetes management market.
The global digital diabetes management market is segmented based on type, product and region. Based on type, the market is categorized into Handheld Devices and Wearable Devices. Based on product, the digital diabetes management market divided into Continuous blood glucose monitoring systems, Smart Glucose Meter, Smart Insulin Pumps, Smart Insulin Pens and Apps. Based on region, the market is analyzed across North America, Europe, Asia-Pacific and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a detailed quantitative analysis of the current market trends and future estimations from 2019-2026, which assists to identify the prevailing market opportunities.
- An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
- A comprehensive analysis of the factors that drive and restrain the growth of the global clinical nutritionmarket is provided.
- An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
ByType
- Handheld Devices
- Wearable Devices
- Continuous blood glucose monitoring systems
- Smart Glucose Meter
- Smart Insulin Pumps
- Smart Insulin Pens
- Apps
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- Spain
- Italy
- UK
- Rest of Europe
- Asia-Pacific
- Japan
- India
- China
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Abbott laboratories
- ACON Laboratories, Inc.
- Bayer AG
- Becton, Dickinson and Company
- Dexcom, Inc
- F. Hoffmann-La Roche Ltd.
- Johnson and Johnson, Medtronic Plc
- Novo Nordisk A/S
- Terumo corporation
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Market dynamics
3.3.1. Drivers
3.3.1.1. Increase in adoption of smartphones & tablets integrated with healthcare apps
3.3.1.2. Surge in diabetic population globally
3.3.2. Restraint
3.3.2.1. Lack of awareness regarding digital diabetes management in developing countries
3.3.2.2. Patient data privacy concerns
3.3.3. Opportunity
3.3.3.1. High growth potential offered by emerging markets
CHAPTER 4: DIGITAL DIABETES MANAGEMENT MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Handheld devices
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market analysis, by region
4.2.3. Market analysis, by country
4.3. Wearable devices
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market analysis, by region
4.3.3. Market analysis, by country
CHAPTER 5: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Continuous blood glucose monitoring systems
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Smart glucose meter
5.3.1. Market analysis, by region
5.3.2. Market analysis, by country
5.4. Smart insulin pumps
5.4.1. Market analysis, by region
5.4.2. Market analysis, by country
5.5. Smart insulin pens
5.5.1. Market analysis, by region
5.5.2. Market analysis, by country
5.6. Apps
5.6.1. Market analysis, by region
5.6.2. Market analysis, by country
CHAPTER 6: DIGITAL DIABETES MANAGEMENT MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. Market size and forecast, by country
6.2.3. Market size and forecast, by type
6.2.4. Market size and forecast, by product
6.2.5.1. U.S. market size and forecast, by type
6.2.5.2. U.S. market size and forecast, by product
6.2.5.3. Canada market size and forecast, By type
6.2.5.4. Canada market size and forecast, by product
6.2.5.5. Mexico market size and forecast, By type
6.2.5.6. Mexico market size and forecast, by product
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Market size and forecast, by country
6.3.3. Market size and forecast, by type
6.3.4. Market size and forecast, by product
6.3.4.1. Germany market size and forecast, by type
6.3.4.2. Germany market size and forecast, by product
6.3.4.3. France market size and forecast, by type
6.3.4.4. France market size and forecast, by product
6.3.4.5. UK market size and forecast, by type
6.3.4.6. UK market size and forecast, by product
6.3.4.7. Italy market size and forecast, by type
6.3.4.8. Italy market size and forecast, by product
6.3.4.9. Rest of Europe market size and forecast, by type
6.3.4.10. Rest of Europe market size and forecast, by product
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Market size and forecast, by country
6.4.3. Market size and forecast, by type
6.4.4. Market size and forecast, by product
6.4.4.1. Japan market size and forecast, by type
6.4.4.2. Japan market size and forecast, by product
6.4.4.3. China market size and forecast, by type
6.4.4.4. China market size and forecast, by product
6.4.4.5. India market size and forecast, by type
6.4.4.6. India market size and forecast, by product
6.4.4.7. Australia market size and forecast, by type
6.4.4.8. Australia market size and forecast, by product
6.4.4.9. Rest of Asia-Pacific market size and forecast, by type
6.4.4.10. Rest of Asia-Pacific market size and forecast, by product
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. Market size and forecast, by country
6.5.3. Market size and forecast, by type
6.5.4. Market size and forecast, by product
6.5.4.1. Brazil market size and forecast, by type
6.5.4.2. Brazil market size and forecast, by product
6.5.4.3. Saudi Arabia market size and forecast, by type
6.5.4.4. Saudi Arabia market size and forecast, by product
6.5.4.5. South Africa market size and forecast, by type
6.5.4.6. South Africa market size and forecast, by product
6.5.4.7. Rest of LAMEA market size and forecast, by type
6.5.4.8. Rest of LAMEA market size and forecast, by product
CHAPTER 7: COMPANY PROFILES
7.1. Abbott laboratories
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. ACON LABORATORIES, INC.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Key strategic moves and developments
7.3. Bayer AG.
7.3.1. Company overview
7.3.2. Operating business segments
7.3.3. Product portfolio
7.3.4. Business performance
7.3.5. Key strategic moves and developments
7.4. BECTON, DICKINSON AND COMPANY
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.5. DEXCOM, INC
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. F. HOFFMANN-LA ROCHE LTD.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. Johnson and Johnson
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. Medtronic Plc.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. NOVO NORDISK A/S
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.10. Terumo corporation.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Market dynamics
3.3.1. Drivers
3.3.1.1. Increase in adoption of smartphones & tablets integrated with healthcare apps
3.3.1.2. Surge in diabetic population globally
3.3.2. Restraint
3.3.2.1. Lack of awareness regarding digital diabetes management in developing countries
3.3.2.2. Patient data privacy concerns
3.3.3. Opportunity
3.3.3.1. High growth potential offered by emerging markets
CHAPTER 4: DIGITAL DIABETES MANAGEMENT MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Handheld devices
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market analysis, by region
4.2.3. Market analysis, by country
4.3. Wearable devices
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market analysis, by region
4.3.3. Market analysis, by country
CHAPTER 5: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Continuous blood glucose monitoring systems
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Smart glucose meter
5.3.1. Market analysis, by region
5.3.2. Market analysis, by country
5.4. Smart insulin pumps
5.4.1. Market analysis, by region
5.4.2. Market analysis, by country
5.5. Smart insulin pens
5.5.1. Market analysis, by region
5.5.2. Market analysis, by country
5.6. Apps
5.6.1. Market analysis, by region
5.6.2. Market analysis, by country
CHAPTER 6: DIGITAL DIABETES MANAGEMENT MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. Market size and forecast, by country
6.2.3. Market size and forecast, by type
6.2.4. Market size and forecast, by product
6.2.5.1. U.S. market size and forecast, by type
6.2.5.2. U.S. market size and forecast, by product
6.2.5.3. Canada market size and forecast, By type
6.2.5.4. Canada market size and forecast, by product
6.2.5.5. Mexico market size and forecast, By type
6.2.5.6. Mexico market size and forecast, by product
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Market size and forecast, by country
6.3.3. Market size and forecast, by type
6.3.4. Market size and forecast, by product
6.3.4.1. Germany market size and forecast, by type
6.3.4.2. Germany market size and forecast, by product
6.3.4.3. France market size and forecast, by type
6.3.4.4. France market size and forecast, by product
6.3.4.5. UK market size and forecast, by type
6.3.4.6. UK market size and forecast, by product
6.3.4.7. Italy market size and forecast, by type
6.3.4.8. Italy market size and forecast, by product
6.3.4.9. Rest of Europe market size and forecast, by type
6.3.4.10. Rest of Europe market size and forecast, by product
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Market size and forecast, by country
6.4.3. Market size and forecast, by type
6.4.4. Market size and forecast, by product
6.4.4.1. Japan market size and forecast, by type
6.4.4.2. Japan market size and forecast, by product
6.4.4.3. China market size and forecast, by type
6.4.4.4. China market size and forecast, by product
6.4.4.5. India market size and forecast, by type
6.4.4.6. India market size and forecast, by product
6.4.4.7. Australia market size and forecast, by type
6.4.4.8. Australia market size and forecast, by product
6.4.4.9. Rest of Asia-Pacific market size and forecast, by type
6.4.4.10. Rest of Asia-Pacific market size and forecast, by product
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. Market size and forecast, by country
6.5.3. Market size and forecast, by type
6.5.4. Market size and forecast, by product
6.5.4.1. Brazil market size and forecast, by type
6.5.4.2. Brazil market size and forecast, by product
6.5.4.3. Saudi Arabia market size and forecast, by type
6.5.4.4. Saudi Arabia market size and forecast, by product
6.5.4.5. South Africa market size and forecast, by type
6.5.4.6. South Africa market size and forecast, by product
6.5.4.7. Rest of LAMEA market size and forecast, by type
6.5.4.8. Rest of LAMEA market size and forecast, by product
CHAPTER 7: COMPANY PROFILES
7.1. Abbott laboratories
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. ACON LABORATORIES, INC.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Key strategic moves and developments
7.3. Bayer AG.
7.3.1. Company overview
7.3.2. Operating business segments
7.3.3. Product portfolio
7.3.4. Business performance
7.3.5. Key strategic moves and developments
7.4. BECTON, DICKINSON AND COMPANY
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.5. DEXCOM, INC
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. F. HOFFMANN-LA ROCHE LTD.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. Johnson and Johnson
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. Medtronic Plc.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. NOVO NORDISK A/S
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.10. Terumo corporation.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
LIST OF TABLES
TABLE 01. DIGITAL DIABETES MANAGEMENT MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 02. DIGITAL DIABETES MANAGEMENT MARKET FOR HANDHELD DEVICES, BY REGION, 2018–2026 ($MILLION)
TABLE 03. DIGITAL DIABETES MANAGEMENT MARKET, FOR WEARABLE DEVICES, BY REGION 2018–2026 ($MILLION)
TABLE 04. DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 05. DIGITAL DIABETES MANAGEMENT MARKET FOR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS, BY REGION, 2018–2026 ($MILLION)
TABLE 06. DIGITAL DIABETES MANAGEMENT MARKET FOR SMART GLUCOSE METER, BY REGION, 2018–2026 ($MILLION)
TABLE 07. DIGITAL DIABETES MANAGEMENT MARKET FOR SMART INSULIN PUMPS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 08. DIGITAL DIABETES MANAGEMENT MARKET FOR SMART INSULIN PENS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 09. DIGITAL DIABETES MANAGEMENT MARKET FOR APPS, BY REGION, 2018–2026 ($MILLION)
TABLE 10. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY REGION, 2018-2026 ($MILLION)
TABLE 11. NORTH DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 12. NORTH AMERICA DIGITAL DIABETES MANAGEMENT MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 13. NORTH AMERICA DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 14. U.S DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026 ($MILLION)
TABLE 15. U.S. DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026 ($MILLION)
TABLE 16. CANADA DIGITAL DIABETES MANAGEMENT MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 17. CANADA DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026 ($MILLION)
TABLE 18. MEXICO DIGITAL DIABETES MANAGEMENT MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 19. MEXICO DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026 ($MILLION)
TABLE 20. EUROPE DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 21. EUROPE DIGITAL DIABETES MANAGEMENT MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 22. EUROPE DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 23. GERMANY DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 24. GERMANY DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 25. FRANCE DIGITAL DIABETES MANAGEMENT MARKET BY TYPE 2018-2026, ($MILLION)
TABLE 26. FRANCE DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 27. UK DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 28. UK DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 29. ITALY DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 30. ITALY DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 31. REST OF EUROPE DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 32. REST OF EUROPE DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 33. ASIA-PACIFIC DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 34. ASIA-PACIFIC DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 35. ASIA-PACIFIC DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 36. JAPAN DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 37. JAPAN DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 38. CHINA DIGITAL DIABETES MANAGEMENT MARKET BY, TYPE 2018-2026, ($MILLION)
TABLE 39. CHINA DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 40. INDIA DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 41. INDIA DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 42. AUSTRALIA DIGITAL DIABETES MANAGEMENT MARKET BY TYPE 2018-2026, ($MILLION)
TABLE 43. AUSTRALIA DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 44. REST OF ASIA-PACIFIC DIGITAL DIABETES MANAGEMENT MARKET BY TYPE 2018-2026, ($MILLION)
TABLE 45. REST OF ASIA-PACIFIC DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 46. LAMEA DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 47. LAMEA DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 48. LAMEA DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 49. BRAZIL DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 50. BRAZIL DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 51. SAUDI ARABIA DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 52. SAUDI ARABIA DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 53. SOUTH AFRICA DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 54. SOUTH AFRICA DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 55. REST OF LAMEA DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 56. REST OF LAMEA DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 57. ABBOTT: COMPANY SNAPSHOT
TABLE 58. ABBOTT: OPERATING SEGMENTS
TABLE 59. ABBOTT: PRODUCT PORTFOLIO
TABLE 60. ACON: COMPANY SNAPSHOT
TABLE 61. ACON: PRODUCT PORTFOLIO
TABLE 62. BAYER: COMPANY SNAPSHOT
TABLE 63. BAYER: OPERATING SEGMENTS
TABLE 64. BAYER: PRODUCT PORTFOLIO
TABLE 65. BD: COMPANY SNAPSHOT
TABLE 66. BD: OPERATING SEGMENTS
TABLE 67. BD: PRODUCT PORTFOLIO
TABLE 68. DEXCOM: COMPANY SNAPSHOT
TABLE 69. DEXCOM: PRODUCT PORTFOLIO
TABLE 70. ROCHE., INC: COMPANY SNAPSHOT
TABLE 71. ROCHE: OPERATING SEGMENTS
TABLE 72. ROCHE: PRODUCT PORTFOLIO
TABLE 73. J&J: COMPANY SNAPSHOT
TABLE 74. J&J: OPERATING SEGMENTS
TABLE 75. J&J: PRODUCT PORTFOLIO
TABLE 76. MEDTRONIC: COMPANY SNAPSHOT
TABLE 77. MEDTRONIC: OPERATING BUSINESS SEGMENTS
TABLE 78. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 79. NOVO NORDISK: COMPANY SNAPSHOT
TABLE 80. NOVO NORDISK: OPERATING SEGMENTS
TABLE 81. NOVO NORDISK: PRODUCT PORTFOLIO
TABLE 82. TERUMO CORPORATION.: COMPANY SNAPSHOT
TABLE 83. TERUMO CORPORATION.: OPERATING SEGMENTS
TABLE 84. TERUMO CORPORATION.: PRODUCT PORTFOLIO
TABLE 01. DIGITAL DIABETES MANAGEMENT MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 02. DIGITAL DIABETES MANAGEMENT MARKET FOR HANDHELD DEVICES, BY REGION, 2018–2026 ($MILLION)
TABLE 03. DIGITAL DIABETES MANAGEMENT MARKET, FOR WEARABLE DEVICES, BY REGION 2018–2026 ($MILLION)
TABLE 04. DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 05. DIGITAL DIABETES MANAGEMENT MARKET FOR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS, BY REGION, 2018–2026 ($MILLION)
TABLE 06. DIGITAL DIABETES MANAGEMENT MARKET FOR SMART GLUCOSE METER, BY REGION, 2018–2026 ($MILLION)
TABLE 07. DIGITAL DIABETES MANAGEMENT MARKET FOR SMART INSULIN PUMPS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 08. DIGITAL DIABETES MANAGEMENT MARKET FOR SMART INSULIN PENS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 09. DIGITAL DIABETES MANAGEMENT MARKET FOR APPS, BY REGION, 2018–2026 ($MILLION)
TABLE 10. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY REGION, 2018-2026 ($MILLION)
TABLE 11. NORTH DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 12. NORTH AMERICA DIGITAL DIABETES MANAGEMENT MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 13. NORTH AMERICA DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 14. U.S DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026 ($MILLION)
TABLE 15. U.S. DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026 ($MILLION)
TABLE 16. CANADA DIGITAL DIABETES MANAGEMENT MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 17. CANADA DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026 ($MILLION)
TABLE 18. MEXICO DIGITAL DIABETES MANAGEMENT MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 19. MEXICO DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026 ($MILLION)
TABLE 20. EUROPE DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 21. EUROPE DIGITAL DIABETES MANAGEMENT MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 22. EUROPE DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 23. GERMANY DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 24. GERMANY DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 25. FRANCE DIGITAL DIABETES MANAGEMENT MARKET BY TYPE 2018-2026, ($MILLION)
TABLE 26. FRANCE DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 27. UK DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 28. UK DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 29. ITALY DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 30. ITALY DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 31. REST OF EUROPE DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 32. REST OF EUROPE DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 33. ASIA-PACIFIC DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 34. ASIA-PACIFIC DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 35. ASIA-PACIFIC DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 36. JAPAN DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 37. JAPAN DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 38. CHINA DIGITAL DIABETES MANAGEMENT MARKET BY, TYPE 2018-2026, ($MILLION)
TABLE 39. CHINA DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 40. INDIA DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 41. INDIA DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 42. AUSTRALIA DIGITAL DIABETES MANAGEMENT MARKET BY TYPE 2018-2026, ($MILLION)
TABLE 43. AUSTRALIA DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 44. REST OF ASIA-PACIFIC DIGITAL DIABETES MANAGEMENT MARKET BY TYPE 2018-2026, ($MILLION)
TABLE 45. REST OF ASIA-PACIFIC DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 46. LAMEA DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 47. LAMEA DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 48. LAMEA DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 49. BRAZIL DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 50. BRAZIL DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 51. SAUDI ARABIA DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 52. SAUDI ARABIA DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 53. SOUTH AFRICA DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 54. SOUTH AFRICA DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 55. REST OF LAMEA DIGITAL DIABETES MANAGEMENT MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 56. REST OF LAMEA DIGITAL DIABETES MANAGEMENT MARKET BY PRODUCT, 2018-2026, ($MILLION)
TABLE 57. ABBOTT: COMPANY SNAPSHOT
TABLE 58. ABBOTT: OPERATING SEGMENTS
TABLE 59. ABBOTT: PRODUCT PORTFOLIO
TABLE 60. ACON: COMPANY SNAPSHOT
TABLE 61. ACON: PRODUCT PORTFOLIO
TABLE 62. BAYER: COMPANY SNAPSHOT
TABLE 63. BAYER: OPERATING SEGMENTS
TABLE 64. BAYER: PRODUCT PORTFOLIO
TABLE 65. BD: COMPANY SNAPSHOT
TABLE 66. BD: OPERATING SEGMENTS
TABLE 67. BD: PRODUCT PORTFOLIO
TABLE 68. DEXCOM: COMPANY SNAPSHOT
TABLE 69. DEXCOM: PRODUCT PORTFOLIO
TABLE 70. ROCHE., INC: COMPANY SNAPSHOT
TABLE 71. ROCHE: OPERATING SEGMENTS
TABLE 72. ROCHE: PRODUCT PORTFOLIO
TABLE 73. J&J: COMPANY SNAPSHOT
TABLE 74. J&J: OPERATING SEGMENTS
TABLE 75. J&J: PRODUCT PORTFOLIO
TABLE 76. MEDTRONIC: COMPANY SNAPSHOT
TABLE 77. MEDTRONIC: OPERATING BUSINESS SEGMENTS
TABLE 78. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 79. NOVO NORDISK: COMPANY SNAPSHOT
TABLE 80. NOVO NORDISK: OPERATING SEGMENTS
TABLE 81. NOVO NORDISK: PRODUCT PORTFOLIO
TABLE 82. TERUMO CORPORATION.: COMPANY SNAPSHOT
TABLE 83. TERUMO CORPORATION.: OPERATING SEGMENTS
TABLE 84. TERUMO CORPORATION.: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. DIGITAL DIABETES MANAGEMENT MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2016-2019*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2019* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2016-2019*
FIGURE 06. TOP IMPACTING FACTORS
FIGURE 07. COMPARATIVE SHARE ANALYSIS OF DIGITAL DIABETES MANAGEMENT MARKET FOR HANDHELD DEVICES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 08. COMPARATIVE SHARE ANALYSIS OF DIGITAL DIABETES MANAGEMENT MARKET FOR WEARABLE DEVICES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF DIGITAL DIABETES MANAGEMENT MARKET FOR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF DIGITAL DIABETES MANAGEMENT MARKET FOR SMART GLUCOSE METER, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF DIGITAL DIABETES MANAGEMENT MARKET FOR SMART INSULIN PUMPS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF DIGITAL DIABETES MANAGEMENT MARKET FOR SMART INSULIN PENS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF DIGITAL DIABETES MANAGEMENT MARKET FOR APPS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. ABBOTT: NET SALES, 2016–2018 ($MILLION)
FIGURE 15. ABBOTT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 16. ABBOTT: REVENUE SHARE BY REGION, 2018(%)
FIGURE 17. BAYER: NET SALES, 2016–2018 ($MILLION)
FIGURE 18. BAYER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 19. BAYER: REVENUE SHARE BY REGION, 2018(%)
FIGURE 20. BD: NET SALES, 2016–2018 ($MILLION)
FIGURE 21. BD: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 22. BD: REVENUE SHARE BY REGION, 2018(%)
FIGURE 23. DEXCOM: NET SALES, 2016–2018 ($MILLION)
FIGURE 24. DEXCOM: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 25. ROCHE: NET SALES, 2016–2018 ($MILLION)
FIGURE 26. ROCHE: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 27. ROCHE: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 28. J&J: NET SALES, 2016–2018 ($MILLION)
FIGURE 29. J&J: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 30. J&J: REVENUE SHARE BY REGION, 2018(%)
FIGURE 31. MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 32. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 33. MEDTRONIC: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 34. NOVO NORDISK: NET SALES, 2016–2018 ($MILLION)
FIGURE 35. NOVO NORDISK: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 36. NOVO NORDISK: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 37. TERUMO CORPORATION, 2016–2018 ($MILLION)
FIGURE 38. TERUMO CORPORATION: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 39. TERUMO CORPORATION: REVENUE SHARE BY REGION, BY 2018%
FIGURE 01. DIGITAL DIABETES MANAGEMENT MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2016-2019*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2019* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2016-2019*
FIGURE 06. TOP IMPACTING FACTORS
FIGURE 07. COMPARATIVE SHARE ANALYSIS OF DIGITAL DIABETES MANAGEMENT MARKET FOR HANDHELD DEVICES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 08. COMPARATIVE SHARE ANALYSIS OF DIGITAL DIABETES MANAGEMENT MARKET FOR WEARABLE DEVICES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF DIGITAL DIABETES MANAGEMENT MARKET FOR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF DIGITAL DIABETES MANAGEMENT MARKET FOR SMART GLUCOSE METER, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF DIGITAL DIABETES MANAGEMENT MARKET FOR SMART INSULIN PUMPS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF DIGITAL DIABETES MANAGEMENT MARKET FOR SMART INSULIN PENS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF DIGITAL DIABETES MANAGEMENT MARKET FOR APPS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. ABBOTT: NET SALES, 2016–2018 ($MILLION)
FIGURE 15. ABBOTT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 16. ABBOTT: REVENUE SHARE BY REGION, 2018(%)
FIGURE 17. BAYER: NET SALES, 2016–2018 ($MILLION)
FIGURE 18. BAYER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 19. BAYER: REVENUE SHARE BY REGION, 2018(%)
FIGURE 20. BD: NET SALES, 2016–2018 ($MILLION)
FIGURE 21. BD: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 22. BD: REVENUE SHARE BY REGION, 2018(%)
FIGURE 23. DEXCOM: NET SALES, 2016–2018 ($MILLION)
FIGURE 24. DEXCOM: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 25. ROCHE: NET SALES, 2016–2018 ($MILLION)
FIGURE 26. ROCHE: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 27. ROCHE: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 28. J&J: NET SALES, 2016–2018 ($MILLION)
FIGURE 29. J&J: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 30. J&J: REVENUE SHARE BY REGION, 2018(%)
FIGURE 31. MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 32. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 33. MEDTRONIC: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 34. NOVO NORDISK: NET SALES, 2016–2018 ($MILLION)
FIGURE 35. NOVO NORDISK: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 36. NOVO NORDISK: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 37. TERUMO CORPORATION, 2016–2018 ($MILLION)
FIGURE 38. TERUMO CORPORATION: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 39. TERUMO CORPORATION: REVENUE SHARE BY REGION, BY 2018%
